Davila, M. L., & Brentjens, R. J. (2016). CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. Clin Adv Hematol Oncol.
Chicago-стиль цитированияDavila, Marco L., and Renier J. Brentjens. "CD19-Targeted CAR T Cells As Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia." Clin Adv Hematol Oncol 2016.
MLA-цитированиеDavila, Marco L., and Renier J. Brentjens. "CD19-Targeted CAR T Cells As Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia." Clin Adv Hematol Oncol 2016.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.